Your browser is no longer supported. Please, upgrade your browser.
Settings
AUTL Autolus Therapeutics plc daily Stock Chart
AUTL [NASD]
Autolus Therapeutics plc
Index- P/E- EPS (ttm)-2.87 Insider Own26.63% Shs Outstand44.62M Perf Week4.95%
Market Cap681.83M Forward P/E- EPS next Y-3.06 Insider Trans0.00% Shs Float8.84M Perf Month27.82%
Income-123.80M PEG- EPS next Q-0.70 Inst Own31.90% Short Float8.98% Perf Quarter59.27%
Sales2.90M P/S235.12 EPS this Y-448.30% Inst Trans19.86% Short Ratio5.33 Perf Half Y-17.46%
Book/sh5.71 P/B2.30 EPS next Y-7.40% ROA- Target Price- Perf Year-20.65%
Cash/sh4.06 P/C3.24 EPS next 5Y- ROE- 52W Range3.00 - 19.34 Perf YTD-0.45%
Dividend- P/FCF- EPS past 5Y- ROI-51.40% 52W High-32.06% Beta-
Dividend %- Quick Ratio10.00 Sales past 5Y- Gross Margin- 52W Low338.00% ATR0.77
Employees290 Current Ratio10.00 Sales Q/Q- Oper. Margin- RSI (14)71.62 Volatility6.02% 7.17%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume1.38 Prev Close13.05
ShortableYes LT Debt/Eq0.00 EarningsMay 07 BMO Payout- Avg Volume148.86K Price13.14
Recom1.90 SMA2015.40% SMA5039.99% SMA20019.53% Volume204,842 Change0.69%
Apr-22-20Initiated Mizuho Buy $18
Sep-23-19Initiated Needham Buy $26
May-17-19Reiterated H.C. Wainwright Buy $45 → $41
Oct-24-18Initiated H.C. Wainwright Buy $45
Jun-03-20 06:28AM  
Jun-02-20 08:07AM  
May-29-20 07:37AM  
May-26-20 07:00AM  
May-22-20 07:00AM  
May-15-20 11:20AM  
07:00AM  
May-14-20 07:00AM  
May-13-20 09:27AM  
May-12-20 12:00PM  
10:52AM  
May-10-20 08:26AM  
May-09-20 11:01PM  
08:26AM  
May-07-20 08:06AM  
07:00AM  
May-01-20 07:00AM  
Apr-16-20 07:00AM  
Mar-03-20 07:07AM  
Feb-25-20 07:00AM  
Feb-24-20 07:00AM  
Jan-30-20 07:00AM  
Jan-27-20 04:00PM  
07:00AM  
Jan-22-20 09:41PM  
04:41PM  
Jan-13-20 07:00AM  
Jan-08-20 11:48AM  
Dec-20-19 06:30AM  
Dec-18-19 07:59AM  
Dec-14-19 07:47PM  
Dec-08-19 09:15AM  
Dec-07-19 02:00PM  
08:35AM  
Dec-05-19 04:30PM  
Nov-27-19 07:03AM  
Nov-18-19 04:52AM  
Nov-13-19 04:02PM  
06:30AM  
Nov-09-19 07:00AM  
Nov-07-19 07:06AM  
Nov-06-19 09:24AM  
Nov-05-19 09:35AM  
09:10AM  
Oct-31-19 06:30AM  
Oct-30-19 07:01PM  
Oct-08-19 08:00AM  
Oct-03-19 09:08AM  
Sep-19-19 08:53AM  
Sep-16-19 10:34AM  
Sep-03-19 02:00AM  
Aug-28-19 04:05PM  
Aug-09-19 02:24AM  
Aug-08-19 07:49AM  
Aug-02-19 09:06AM  
Jul-16-19 10:31AM  
Jun-19-19 08:40AM  
May-28-19 04:55PM  
May-14-19 06:30AM  
06:30AM  
May-07-19 04:05PM  
Apr-29-19 02:52PM  
Apr-23-19 07:49AM  
Apr-15-19 04:02PM  
03:29PM  
Apr-12-19 08:50AM  
Apr-10-19 09:19PM  
Apr-08-19 04:40PM  
Apr-01-19 02:29PM  
01:05PM  
Mar-29-19 04:05PM  
04:03PM  
Mar-26-19 06:00AM  
Mar-07-19 04:05PM  
Mar-04-19 04:05PM  
06:30AM  
Feb-25-19 06:15AM  
06:00AM  
Feb-21-19 06:30AM  
Feb-19-19 09:08AM  
06:30AM  
Jan-16-19 09:05AM  
Jan-14-19 08:28AM  
07:55AM  
Jan-09-19 07:02PM  
12:20PM  
Dec-20-18 04:32PM  
Dec-03-18 03:27AM  
03:25AM  
Dec-02-18 11:01AM  
Dec-01-18 09:16PM  
Nov-23-18 08:30AM  
Nov-02-18 07:42AM  
Nov-01-18 09:10AM  
Oct-30-18 08:30AM  
Oct-17-18 08:30AM  
Sep-27-18 08:20PM  
Aug-30-18 08:33AM  
Jun-22-18 08:13PM  
07:07PM  
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of hematological malignancies and solid tumors. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 for the treatment of multiple myeloma; AUTO4 and AUTO 5 for T cell lymphoma; and AUTO6 and AUTO7 to treat solid tumors. The company was founded in 2014 and is headquartered in London, the United Kingdom.